Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hyphens Pharma International Ltd. ( (SG:1J5) ) has provided an update.
Hyphens Pharma has expanded its agreement with Medac to include the commercialization of the Metoject® subcutaneous autoinjector pen in Thailand and Cambodia. This extension builds on an existing agreement covering Singapore, Malaysia, the Philippines, and Vietnam, further solidifying Hyphens Pharma’s presence in Southeast Asia and demonstrating its commitment to delivering innovative healthcare solutions in the region.
More about Hyphens Pharma International Ltd.
Hyphens Pharma International Ltd. is a leading specialty pharmaceutical and consumer healthcare group based in Singapore. The company focuses on providing innovative treatments and healthcare solutions across Southeast Asia.
Average Trading Volume: 240,365
Technical Sentiment Signal: Buy
Current Market Cap: S$111.3M
For an in-depth examination of 1J5 stock, go to TipRanks’ Overview page.